Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000456880 | SCV000545468 | likely benign | Hereditary diffuse gastric adenocarcinoma | 2023-10-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000609431 | SCV000723781 | likely benign | not specified | 2017-10-13 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Color Diagnostics, |
RCV000774766 | SCV000908731 | uncertain significance | Hereditary cancer-predisposing syndrome | 2024-01-17 | criteria provided, single submitter | clinical testing | This variant causes an A to G nucleotide substitution at the +9 position of intron 8 of the CDH1 gene. Splice site prediction tools suggest that this variant may not impact RNA splicing. To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual affected with an unspecified cancer that was not diffuse gastric or lobular breast cancer (PMID: 36436516). This variant has been identified in 3/251452 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |
European Reference Network on Genetic Tumour Risk Syndromes |
RCV000456880 | SCV003926735 | uncertain significance | Hereditary diffuse gastric adenocarcinoma | 2022-08-01 | criteria provided, single submitter | clinical testing | Not applicable criteria (PMID: 30311375) |